These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

258 related items for PubMed ID: 25496649

  • 1. Inhibition of GPR30 by estriol prevents growth stimulation of triple-negative breast cancer cells by 17β-estradiol.
    Girgert R, Emons G, Gründker C.
    BMC Cancer; 2014 Dec 11; 14():935. PubMed ID: 25496649
    [Abstract] [Full Text] [Related]

  • 2. 17β-estradiol-induced growth of triple-negative breast cancer cells is prevented by the reduction of GPER expression after treatment with gefitinib.
    Girgert R, Emons G, Gründker C.
    Oncol Rep; 2017 Feb 11; 37(2):1212-1218. PubMed ID: 27959426
    [Abstract] [Full Text] [Related]

  • 3. Inactivation of GPR30 reduces growth of triple-negative breast cancer cells: possible application in targeted therapy.
    Girgert R, Emons G, Gründker C.
    Breast Cancer Res Treat; 2012 Jul 11; 134(1):199-205. PubMed ID: 22290080
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of growth hormone receptor by Somavert reduces expression of GPER and prevents growth stimulation of triple-negative breast cancer by 17β-estradiol.
    Girgert R, Emons G, Gründker C.
    Oncol Lett; 2018 Jun 11; 15(6):9559-9566. PubMed ID: 29805678
    [Abstract] [Full Text] [Related]

  • 5. GPER mediates enhanced cell viability and motility via non-genomic signaling induced by 17β-estradiol in triple-negative breast cancer cells.
    Yu T, Liu M, Luo H, Wu C, Tang X, Tang S, Hu P, Yan Y, Wang Z, Tu G.
    J Steroid Biochem Mol Biol; 2014 Sep 11; 143():392-403. PubMed ID: 24874276
    [Abstract] [Full Text] [Related]

  • 6. G protein-coupled receptor 30 (GPR30) mediates gene expression changes and growth response to 17beta-estradiol and selective GPR30 ligand G-1 in ovarian cancer cells.
    Albanito L, Madeo A, Lappano R, Vivacqua A, Rago V, Carpino A, Oprea TI, Prossnitz ER, Musti AM, Andò S, Maggiolini M.
    Cancer Res; 2007 Feb 15; 67(4):1859-66. PubMed ID: 17308128
    [Abstract] [Full Text] [Related]

  • 7. Estrogen action via the G protein-coupled receptor, GPR30: stimulation of adenylyl cyclase and cAMP-mediated attenuation of the epidermal growth factor receptor-to-MAPK signaling axis.
    Filardo EJ, Quinn JA, Frackelton AR, Bland KI.
    Mol Endocrinol; 2002 Jan 15; 16(1):70-84. PubMed ID: 11773440
    [Abstract] [Full Text] [Related]

  • 8. Focal adhesion kinase (FAK) activation by estrogens involves GPER in triple-negative breast cancer cells.
    Rigiracciolo DC, Santolla MF, Lappano R, Vivacqua A, Cirillo F, Galli GR, Talia M, Muglia L, Pellegrino M, Nohata N, Di Martino MT, Maggiolini M.
    J Exp Clin Cancer Res; 2019 Feb 06; 38(1):58. PubMed ID: 30728047
    [Abstract] [Full Text] [Related]

  • 9. Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF.
    Filardo EJ, Quinn JA, Bland KI, Frackelton AR.
    Mol Endocrinol; 2000 Oct 06; 14(10):1649-60. PubMed ID: 11043579
    [Abstract] [Full Text] [Related]

  • 10. The G protein-coupled receptor GPR30 mediates c-fos up-regulation by 17beta-estradiol and phytoestrogens in breast cancer cells.
    Maggiolini M, Vivacqua A, Fasanella G, Recchia AG, Sisci D, Pezzi V, Montanaro D, Musti AM, Picard D, Andò S.
    J Biol Chem; 2004 Jun 25; 279(26):27008-16. PubMed ID: 15090535
    [Abstract] [Full Text] [Related]

  • 11. Interaction Between CCL18 and GPR30 Differs from the Interaction Between Estradiol and GPR30.
    Schmidt-Wolf R, Zissel G.
    Anticancer Res; 2020 Jun 25; 40(6):3097-3108. PubMed ID: 32487604
    [Abstract] [Full Text] [Related]

  • 12. 17beta-estradiol, genistein, and 4-hydroxytamoxifen induce the proliferation of thyroid cancer cells through the g protein-coupled receptor GPR30.
    Vivacqua A, Bonofiglio D, Albanito L, Madeo A, Rago V, Carpino A, Musti AM, Picard D, Andò S, Maggiolini M.
    Mol Pharmacol; 2006 Oct 25; 70(4):1414-23. PubMed ID: 16835357
    [Abstract] [Full Text] [Related]

  • 13. The G protein-coupled receptor GPR30 inhibits human urothelial cell proliferation.
    Teng J, Wang ZY, Prossnitz ER, Bjorling DE.
    Endocrinology; 2008 Aug 25; 149(8):4024-34. PubMed ID: 18467434
    [Abstract] [Full Text] [Related]

  • 14. The G protein-coupled receptor GPR30 inhibits proliferation of estrogen receptor-positive breast cancer cells.
    Ariazi EA, Brailoiu E, Yerrum S, Shupp HA, Slifker MJ, Cunliffe HE, Black MA, Donato AL, Arterburn JB, Oprea TI, Prossnitz ER, Dun NJ, Jordan VC.
    Cancer Res; 2010 Feb 01; 70(3):1184-94. PubMed ID: 20086172
    [Abstract] [Full Text] [Related]

  • 15. Nuclear alternate estrogen receptor GPR30 mediates 17beta-estradiol-induced gene expression and migration in breast cancer-associated fibroblasts.
    Madeo A, Maggiolini M.
    Cancer Res; 2010 Jul 15; 70(14):6036-46. PubMed ID: 20551055
    [Abstract] [Full Text] [Related]

  • 16. 17β-Estradiol on the Expression of G-Protein Coupled Estrogen Receptor (GPER/GPR30) Mitophagy, and the PI3K/Akt Signaling Pathway in ATDC5 Chondrocytes In Vitro.
    Fan DX, Yang XH, Li YN, Guo L.
    Med Sci Monit; 2018 Apr 02; 24():1936-1947. PubMed ID: 29608013
    [Abstract] [Full Text] [Related]

  • 17. The G protein-coupled receptor GPR30 mediates the proliferative effects induced by 17beta-estradiol and hydroxytamoxifen in endometrial cancer cells.
    Vivacqua A, Bonofiglio D, Recchia AG, Musti AM, Picard D, Andò S, Maggiolini M.
    Mol Endocrinol; 2006 Mar 02; 20(3):631-46. PubMed ID: 16239258
    [Abstract] [Full Text] [Related]

  • 18. Assessment of cell line competence for studies of pharmacological GPR30 modulation.
    Sousa C, Ribeiro M, Rufino AT, Leitão AJ, Mendes AF.
    J Recept Signal Transduct Res; 2017 Apr 02; 37(2):181-188. PubMed ID: 27401115
    [Abstract] [Full Text] [Related]

  • 19. The novel estrogen receptor, G protein-coupled receptor 30, mediates the proliferative effects induced by 17beta-estradiol on mouse spermatogonial GC-1 cell line.
    Sirianni R, Chimento A, Ruggiero C, De Luca A, Lappano R, Andò S, Maggiolini M, Pezzi V.
    Endocrinology; 2008 Oct 02; 149(10):5043-51. PubMed ID: 18566133
    [Abstract] [Full Text] [Related]

  • 20. Epidermal growth factor induces G protein-coupled receptor 30 expression in estrogen receptor-negative breast cancer cells.
    Albanito L, Sisci D, Aquila S, Brunelli E, Vivacqua A, Madeo A, Lappano R, Pandey DP, Picard D, Mauro L, Andò S, Maggiolini M.
    Endocrinology; 2008 Aug 02; 149(8):3799-808. PubMed ID: 18467441
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.